Remdesivir News and Research

RSS
New research on nirmatrelvir resistance in SARS-CoV-2 using powerful replicon cell culture systems

New research on nirmatrelvir resistance in SARS-CoV-2 using powerful replicon cell culture systems

Phase III trial shows noninferiority of VV116 compared to nirmatrelvir–ritonavir among adults with mild-to-moderate COVID-19 at risk of progression

Phase III trial shows noninferiority of VV116 compared to nirmatrelvir–ritonavir among adults with mild-to-moderate COVID-19 at risk of progression

Does nirmatrelvir and ritonavir reduce the risk of hospitalization or death among outpatients with early COVID-19?

Does nirmatrelvir and ritonavir reduce the risk of hospitalization or death among outpatients with early COVID-19?

Study finds bebtelovimab therapy lacks efficacy in patients infected with SARS-CoV-2 Omicron subvariants

Study finds bebtelovimab therapy lacks efficacy in patients infected with SARS-CoV-2 Omicron subvariants

Is remdesivir treatment associated with reduced risk of inpatient mortality among US patients hospitalized with COVID-19?

Is remdesivir treatment associated with reduced risk of inpatient mortality among US patients hospitalized with COVID-19?

Exploring clinical characteristics and outcomes of hospitalized COVID-19 patients

Exploring clinical characteristics and outcomes of hospitalized COVID-19 patients

Study aims to develop broad-spectrum antivirals against SARS-CoV-2 via drug repurposing strategies

Study aims to develop broad-spectrum antivirals against SARS-CoV-2 via drug repurposing strategies

Remdesivir appears to make a big difference in Japanese patients with COVID-19

Remdesivir appears to make a big difference in Japanese patients with COVID-19

Study finds a lower compliance rate with recently released guidelines for COVID-19 care

Study finds a lower compliance rate with recently released guidelines for COVID-19 care

Among US veterans with COVID-19, few used antivirals or monoclonal antibodies

Among US veterans with COVID-19, few used antivirals or monoclonal antibodies

Exploring antiviral drug combinations for SARS-CoV-2 suppression

Exploring antiviral drug combinations for SARS-CoV-2 suppression

Outcomes from an Australian COVID-19 virtual ward during Omicron wave

Outcomes from an Australian COVID-19 virtual ward during Omicron wave

Evaluating dual direct-acting antivirals against persistent COVID-19

Evaluating dual direct-acting antivirals against persistent COVID-19

Influenza hospitalizations at highest level in ten years, predicting a severe U.S. flu season

Influenza hospitalizations at highest level in ten years, predicting a severe U.S. flu season

COVID-19 and the gut

COVID-19 and the gut

What is the efficacy of mulberry component Kuwanon C against COVID-19?

What is the efficacy of mulberry component Kuwanon C against COVID-19?

How does COVID-19 and its treatment affect testicular function?

How does COVID-19 and its treatment affect testicular function?

Study reviews hydroxychloroquine and remdesivir antiviral potency against SARS‐CoV‐2

Study reviews hydroxychloroquine and remdesivir antiviral potency against SARS‐CoV‐2

Two cases of acute abdominal pain in patients with COVID-19 in their second week of illness

Two cases of acute abdominal pain in patients with COVID-19 in their second week of illness

Selective immunoglobulin A deficiency a risk factor for severe COVID-19

Selective immunoglobulin A deficiency a risk factor for severe COVID-19

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.